H4ZP:XETRA:XETRA-HSBC MSCI China UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.308

Change

-0.05 (-0.79)%

Market Cap

USD 0.77B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.89 (+1.76%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.28 (+1.72%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.42 (+1.57%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.45 (+1.61%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.42 (+1.73%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.87 (+1.94%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+2.20 (+1.54%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.84 (+1.68%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+3.07 (+3.13%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+23.06 (+4.12%)

USD 80.38B

ETFs Containing H4ZP:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.05% 86% B+ 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.05% 86% B+ 85% B
Trailing 12 Months  
Capital Gain 15.72% 51% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.72% 51% F 55% F
Trailing 5 Years  
Capital Gain -14.54% 11% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.54% 11% F 25% F
Average Annual (5 Year Horizon)  
Capital Gain -7.49% 6% D- 9% A-
Dividend Return -7.49% 6% D- 8% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.03% 24% F 37% F
Risk Adjusted Return -41.56% 15% F 14% F
Market Capitalization 0.77B 73% C 64% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.